Federal auditors determined terminations from the 340B program were required for either covered entity sites or contract pharmacies of four [...] …
Category: Regulatory
Both sides in a lawsuit over New York state’s transfer of Medicaid managed care drug benefits to Medicaid fee for [...] …
The 340B program has provided a range of benefits but also needs reforms, according to a recent review of published [...] …
Two drugmakers will offer refunds to 340B providers for overcharges in recent years. Drug manufacturer Mallinckrodt’s SpecGx generic pharmaceutical subsidiary [...] …
Apexus, the 340B prime vendor, asked a federal appeals court to affirm a lower court’s dismissal of claims that it [...] …
Jazz Pharmaceuticals owes refunds to 340B providers, according to a notice posted on the Health Resources and Services Administration’s Office [...] …
Hospital groups will meet with federal executive branch officials to discuss coming changes to the 340B program’s administrative dispute resolution [...] …
GlaxoSmithKline owes refunds to 340B providers, according to a notice posted on the Health Resources and Services Administration’s Office of [...] …
A recent ruling by a federal district judge in South Carolina potentially could expand 340B-eligible prescriptions, say some provider advisers. [...] …
Hospital advocates praised the recent Medicare final rule implementing a $9 billion lump sum payment to 340B hospitals but worried [...] …